Clinical trial
High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated…
NCT00263185 · Washington University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00263185 |
|---|---|
| Title | High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Status |
| Official title | A Double-Blind, Randomized, Placebo Controlled Trial of High Dose Vitamin D Therapy On Musculoskeletal Symptoms and Bone Mineral Density in Anastrozole-Treated Early Stage Breast Cancer Patients With Marginal Vitamin D Status |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Dietary Supplement, Drug, Other |
| Interventions | Vitamin D, Calcium carbonate, Placebo |
| Enrollment | 63 |
| Start date | Nov 1, 2005 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Dec 7, 2005 |
| Last update posted | Sep 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: